Concepedia

Emyr Bakker

EB

Statistics

Publications

6

Citations

129

H-Index

6

Active since

2012

Affiliations

University of Lancashire(Current)

University of Salford

University of Manchester

Temple University

Emyr Bakker is an author at University of Lancashire specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2012–2023

6

Publications

6

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment

Alice Guazzelli, Parisa Meysami, Emyr Bakker et al. · International Journal of Molecular Sciences · 2019 · 57 citations · Full text

, , +17

p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification

Kun Tian, Emyr Bakker, Michelle Hussain et al. · Journal of Translational Medicine · 2018 · 26 citations · Full text

, , +17

No Evidence for JAK2<sup>V617F</sup> Mutation in Monoclonal B Cells in 2 Patients with Polycythaemia Vera and Concurrent Monoclonal B Cell Disorder

Cornelis Stijnis, Wilma G. M. Kroes, Sahila Balkassmi et al. · Acta Haematologica · 2012 · 15 citations

, , +15

Intratumor microbiota as a novel potential prognostic indicator in mesothelioma

Francesca Pentimalli, Marija Krstic–Demonacos, Caterina Costa et al. · Frontiers in Immunology · 2023 · 11 citations · Full text

, , +17

Molecular Mechanisms of PD-1 and PD-L1 Activity on a Pan-Cancer Basis: A Bioinformatic Exploratory Study

Siddarth Kannan, Geraldine M. O’Connor, Emyr Bakker · International Journal of Molecular Sciences · 2021 · 10 citations · Full text

, , +17

1–5 of 6